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Production of mycobacterial cell wall
glycopeptidolipids requires a member of the
MbtH-like protein family
Elizabeth Tatham1†, Sivagami sundaram Chavadi1†, Poornima Mohandas1, Uthamaphani R Edupuganti1,
Shiva K Angala2, Delphi Chatterjee2 and Luis E N Quadri1*
Abstract
Background: Glycopeptidolipids (GPLs) are among the major free glycolipid components of the outer membrane
of several saprophytic and clinically-relevant Mycobacterium species. The architecture of GPLs is based on a
constant tripeptide-amino alcohol core of nonribosomal peptide synthetase origin that is N-acylated with a
3-hydroxy/methoxy acyl chain synthesized by a polyketide synthase and further decorated with variable
glycosylation patterns built from methylated and acetylated sugars. GPLs have been implicated in many aspects
of mycobacterial biology, thus highlighting the significance of gaining an understanding of their biosynthesis.
Our bioinformatics analysis revealed that every GPL biosynthetic gene cluster known to date contains a gene
(referred herein to as gplH) encoding a member of the MbtH-like protein family. Herein, we sought to conclusively
establish whether gplH was required for GPL production.
Results: Deletion of gplH, a gene clustered with nonribosomal peptide synthetase-encoding genes in the GPL
biosynthetic gene cluster of Mycobacterium smegmatis, produced a GPL deficient mutant. Transformation of
this mutant with a plasmid expressing gplH restored GPL production. Complementation was also achieved by
plasmid-based constitutive expression of mbtH, a paralog of gplH found in the biosynthetic gene cluster for
production of the siderophore mycobactin of M. smegmatis. Further characterization of the gplH mutant indicated
that it also displayed atypical colony morphology, lack of sliding motility, altered capacity for biofilm formation,
and increased drug susceptibility.
Conclusions: Herein, we provide evidence formally establishing that gplH is essential for GPL production in
M. smegmatis. Inactivation of gplH also leads to a pleiotropic phenotype likely to arise from alterations in the cell
envelope due to the lack of GPLs. While genes encoding MbtH-like proteins have been shown to be needed
for production of siderophores and antibiotics, our study presents the first case of one such gene proven to
be required for production of a cell wall component. Furthermore, our results provide the first example of a
mbtH-like gene with confirmed functional role in a member of the Mycobacterium genus. Altogether, our findings
demonstrate a critical role of gplH in mycobacterial biology and advance our understanding of the genetic
requirements for the biosynthesis of an important group of constituents of the mycobacterial outer membrane.
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Background
The cell envelope of members of the Mycobacterium
genus contains a unique array of structurally-complex
free lipids thought to be non-covalently bound to the
mycolic acid layer of the cell wall [1-3]. These free lipids
are believed to form a membrane outer leaflet that part-
ners with a mycolic acid-based membrane inner leaflet
to form an asymmetric lipid bilayer-like structure. This
lipid bilayer constitutes the distinctive outer membrane
of the mycobacterial cell envelope. The documented role
of some of these free lipids as mycobacterial virulence
effectors highlights the enzymes involved in their pro-
duction as potential target candidates for exploring the
development of novel drugs that could assist conven-
tional antimicrobial therapy in the control of mycobac-
terial infections. Notably, the first inhibitor of the
biosynthesis of a group of these free lipids (i.e., phenolic
glycolipids [3]) has been recently reported [4]. The
inhibitor works in a manner analogous to that of the
first reported inhibitor of siderophore (iron chelator)
biosynthesis [5,6], and it blocks the production of phen-
olic glycolipids in Mycobacterium tuberculosis and other
mycobacterial pathogens [4].
Glycopeptidolipids (GPLs) are among the major free
glycolipid components of the outer membrane of sev-
eral Mycobacterium species [7,8] (Figure 1). The GPL-
producing species include saprophytic mycobacteria, such
as Mycobacterium smegmatis (Ms), and many clinically-
relevant nontuberculous mycobacteria. The members of
the Mycobacterium avium-Mycobacterium intracellulare
complex (MAC) are among the GPL producers of clinical
significance. MAC infections cause pulmonary and extra-
pulmonary diseases in both immunocompromised and
immunocompetent individuals [9,10]. Importantly, GPLs
have been implicated in many aspects of mycobacterial
biology, including host-pathogen interaction [11-17], slid-
ing motility [18,19], and biofilm formation [18,20]. An
altered expression profile of GPLs has been observed in
drug-resistant clinical isolates of MAC [21], a finding that
raises the possibility that GPL production might have
an impact on drug susceptibility as well. Thus, elucidation
of the GPL biosynthetic pathway is important not only
because it will expand our understanding of cell wall bio-
synthesis in mycobacteria, but it may also illuminate
potential routes to alternative therapeutic strategies against
infections by MAC and other opportunistic mycobacterial
human pathogens.
Structures of GPLs from several mycobacteria have
been characterized (reviewed in references [7,8]). In brief,
GPL molecules are composed of an N-acylated lipopep-
tide core decorated by a variable pattern of glycosyla-
tion that is built from O-methylated and O-acetylated
sugar units. The peptide moiety is the tripeptide-
amino alcohol D-phenylalanine-D-allothreonine-D-
alanine-L-alaninol (D-Phe-D-alloThr-D-Ala-L-alaninol).
This tripeptide-amino alcohol is assembled by nonribo-
somal peptide synthetases (NRPSs) designated Mps1 and
Mps2 in Ms [22-25], whereas biosynthesis of the lipid
substituent (3-hydroxy/methoxy C28-C35 acyl chain) is
believed to require a dedicated polyketide synthase (PKS)
[24]. NRPSs and PKSs are two large families of enzymes
that are best known for their involvement in the synthe-
sis of natural products with pharmacological activities of
clinical significance [26,27] and microbial siderophores
[28,29]. N-acylation of the tripeptide-amino alcohol of
Ms GPLs has been proposed to require the protein
PapA3 [24], a member of the polyketide-associated
protein (Pap) family of acyltransferases [30,31]. Lastly,
various glycosyltransferases, methyltransferases and acet-
yltransferases have been implicated or are suspected to
be involved in the building of the glycosyl portion of
GPLs [7,8,24,32].
Despite the increasingly recognized widespread pres-
ence of GPLs in mycobacteria and the relevance of these
compounds in MAC and other mycobacteria of clinical
significance, the GPL biosynthetic pathway remains in-
completely understood. The individual involvement of
several genes suspected to be required for GPL produc-
tion remains to be experimentally probed. In particular,
the involvement of a gene encoding a member of the
MbtH-like protein family (NCBI CDD pfam 03621)
[33,34] and clustered with the NRPS-encoding genes
required for D-Phe-D-alloThr-D-Ala-L-alaninol assembly
in GPL production has been hypothesized [23-25,35], but
not conclusively demonstrated. MbtH-like proteins form
a family of small proteins (60–80 amino acids) linked to
secondary metabolite production pathways involving NRPSs
[34]. The founding member of this protein family is
MbtH, a protein encoded in the mycobactin siderophore
biosynthetic gene cluster of M. tuberculosis [33].
Figure 1 Representative structures of glycopeptidolipids. The depicted GPLs correspond to those found in Mycobacterium smegmatis.
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Recent seminal biochemical studies have established
that MbtH-like proteins activate amino acid adenylation
domains of NRPSs [36-40]. Genes encoding MbtH-like
proteins have been shown to be required for produc-
tion of siderophores or antibiotics by mutational analysis
[41-44]. Interestingly, however, we have recently shown by
mutational analysis that the mbtH orthologue in the myco-
bactin biosynthetic gene cluster of Ms (MSMEG_4508) is
not essential for mycobactin production [35]. Similarly,
the mbtH-like gene in the biosynthetic gene cluster
of the balhimycin glycopeptide antibiotic has been
shown not to be required for antibiotic production [45].
These findings illustrate the well-recognized limitations
of bioinformatics-based genetic predictions in complex
biosynthetic pathways and highlight the need for prob-
ing gene involvement by unconfounded mutational anal-
ysis. In this study, we provide evidence unequivocally
establishing that the conserved mbtH-like gene (herein
referred to as gplH) located in the GPL biosynthetic gene
locus of Ms is essential for GPL production. This finding
presents the first case of a mbtH-like gene required for
biosynthesis of a cell wall component and provides the
first example of a mbtH-like gene with confirmed func-
tional role in a member of the Mycobacterium genus.
Moreover, we show that loss of gplH leads to a mutant
with atypical colony morphology, lack of sliding motility,
reduced biofilm formation capacity, and increased anti-
microbial drug susceptibility. Altogether, this study demon-
strates a critical role for gplH in mycobacterial biology and
advances our understanding of the genetic requirements
for the biosynthesis of an important group of constituents
of the unique mycobacterial outer membrane.
Results and discussion
Conservation of a MbtH homologue in the GPL
biosynthetic pathway
MbtH is a protein encoded in the mycobactin sidero-
phore biosynthetic gene cluster of M. tuberculosis and
the founding member of the MbtH-like protein family
(NCBI CDD pfam 03621) [33]. Our analysis of available
genome sequences of GPL producers revealed that every
GPL biosynthetic gene cluster known to date contains a
mbtH-like gene located upstream of NRPS-encoding
genes required for D-Phe-D-alloThr-D-Ala-L-alaninol
assembly (Figure 2). The MbtH-like protein orthologues
encoded by these mbtH-like genes are comprised of 69–
93 amino acids and have remarkable sequence identity
(80-100%) (Figure 3). This sequence identity extends to
the three fully conserved tryptophan residues that are a
hallmark of the protein family (NCBI CDD pfam 03621)
[33] (Figure 3A). The open reading frame corresponding
to the mbtH-like gene of M. avium 2151 (Figure 2) has
not been previously annotated; however, our genome
sequence analysis revealed its presence. The MbtH-like
protein encoded by this gene is shown in the protein
alignment (Figure 3A). The orthologous mbtH-like
genes or MbtH-like proteins in the other species shown
in Figure 2 have been annotated each as mbtH or MbtH,
respectively [24,46], presumably due to their sequence
relatedness with M. tuberculosis MbtH. This name
assignment is misleading as these genes are not ortholo-
gues of mbtH, the gene of the mycobactin biosynthetic
pathway present in many mycobacteria, including M.
smegmatis, M. abscessus, and M. avium [33,35]. This
name assignment leads to gene nomenclature confusion
by resulting in more than one gene named mbtH in the
same species. We proposed herein to name all the
orthologous mbtH-like genes associated with GPL pro-
duction as gplH, a name derived from glycopeptidolipid
and mbtH and not previously assigned to any mycobac-
terial gene.
Deletion of gplH in M. smegmatis
Our bioinformatics analysis revealed that every GPL bio-
synthetic gene cluster known to date contains a mbtH-
like gene, gplH. The involvement of this conserved gene
in GPL production remains unproven. Herein, we sought
to conclusively establish whether gplH was required for
GPL production. To this end, we engineered Ms ΔgplH,
a mutant with an unmarked, in-frame deletion of gplH
(Figure 4A), the Ms gene upstream of the NRPS-
encoding gene mps1 (Figure 2), and assessed the ability
of this mutant to produce GPLs as described below. Ms
was selected as a representative prototype of GPL pro-
ducers for the studies presented herein due to its super-
ior experimental tractability compared with other GPL
producers (e.g., MAC members).
The gplH deletion was engineered using the gplH
deletion cassette-delivery suicide vector p2NIL-GOALc-
ΔgplH c(~16 kb, Figure 4B) in a homologous
recombination- and counter selection-based approach
that replaced gplH by a 17-codon gene remnant cloned
into the vector. The deletion in Ms ΔgplH encompassed
59 central amino acids of the predicted MbtH-like pro-
tein encoded by gplH (GplH, MSMEG_0399; 76 amino
acids, Figure 3A). The deletion was verified by PCR
using primer pairs that produced amplicons of different
sizes depending on whether the genomic DNA used as
PCR template was wild type (WT) or carried the gene
deletion (Figure 4C). The successful engineering of Ms
ΔgplH set the stage for probing the involvement of gplH
in GPL production.
The gene gplH is essential for GPL production
We investigated the effect of the gplH deletion in Ms
ΔgplH on GPL production using TLC and MS analyses.
In addition, a control strain for genetic complementation
analysis was constructed (Ms ΔgplH+ pCP0-gplH), and
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the ability of this strain and that of Ms WT controls to
produce GPLs was investigated. Representative results
from the TLC analysis are shown in Figure 5. The ana-
lysis of lipid extracts from the parental Ms WT strain, or
Ms WT bearing the empty pCP0 vector, revealed the
expected production of GPLs in these WT controls.
Conversely, analysis of lipid extracts from Ms ΔgplH did
not reveal detectable amounts of GPLs. Transformation
of Ms ΔgplH with pCP0-gplH (a pCP0-based plasmid
expressing gplH) rendered the strain Ms ΔgplH+ pCP0-
gplH, for which TLC analysis demonstrated that produc-
tion of GPLs was restored to levels comparable to those
seen in the WT controls. In contrast, Ms ΔgplH retained
its GPL deficient phenotype after transformation with
empty pCP0 vector (strain Ms ΔgplH+pCP0). The
results of our complementation analysis rule out the
possibility that the GPL deficient phenotype observed in
Ms ΔgplH is due to a polar effect of the gplH deletion
on downstream genes required for GPL production (i.e.,
mps1 and mps2; Figure 2).
The presence of GPLs was probed for in lipid samples
from Ms WT+pCP0, Ms ΔgplH+ pCP0, and Ms
ΔgplH+ pCP0-gplH (complemented strain) by GC-MS
analysis as well. The pCP0-bearing strains, Ms WT+
pCP0 and Ms ΔgplH+ pCP0, rather than their respective
plasmid-free parental strains, were used in these experi-
ments so that the WT, the mutant, and the comple-
mented strain could all be cultured under identical
conditions (i.e., kanamycin-containing growth medium)
for comparative analysis by GC-MS. Representative
Figure 2 Orthologous mbtH-like gene (gplH)-nonribosomal peptide synthetase gene loci involved in GPL production. } Nucleotide
sequence accession numbers (GenBank) of analyzed sequences, protein accession numbers (PAN), available genomic locus tags (GLT), and gene
names are shown. Underlined gene names are proposed herein. ¥M. smegmatis sequence submission AY439015.3 shows a single gene (mps1)
where the annotated complete genome (GenBank: CP000480.1) shows two contiguous genes (MSMEG_0400 and MSMEG_0401). Our sequence
comparison revealed that CP000480.1 has an insertion of a “C” and a deletion of an “A” relative to AY439015.3. The events (112-bp apart) create a
transient frameshift that splits mps1 into MSMEG_0400 and MSMEG_0401. We resequenced the region containing the discrepancies and found
that our sequence matched that of AY439015.3. Based on this and the conservation of mps1 across species, we conclude that the correct gene
organization is as shown herein. †The open reading frame corresponding to this gene has not been previously annotated. {Our sequence
analysis (not shown) indicates that the pstA appears to have originated from an mps1 and mps2 deletion-fusion rearrangement relative to the
canonical mps1 and mps2 seen in M. avium strains 104 and 2151 and other GPL-producing species. This rearrangement leads to a gene encoding
a 4,027-amino acid protein that appears to have segments derived from both Mps1 and Mps2. This protein would not be competent for
D-Phe-D-alloThr-D-Ala-L-alaninol synthesis, a defect that alone would explain the known GPL-deficiency of M. avium subsp. paratuberculosis K-10.
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results from the GC-MS analysis are shown in Figure 6.
This analysis probed for the presence of the alditol acet-
ate derivatives of the characteristic glycosyl residues of
Ms GPLs as a fingerprint indicator of the presence of
GPLs in the lipid samples analyzed [47]. The GC-MS
analysis of samples from Ms WT+pCP0 revealed the
expected m/z peak array consistent with the charac-
teristic presence of alditol acetate derivatives of the
2,3,4-trimethyl-rhamnose, 3,4-dimethyl-rhamnose and 6-
deoxy-talose components of GPLs [7,8,47]. Conversely,
these alditol acetate derivatives were not detected by
GC-MS analysis of samples from Ms ΔgplH+ pCP0. The
samples from the complemented strain, Ms ΔgplH+
pCP0-gplH, displayed an m/z peak array comparable to
that of Ms WT+pCP0 and consistent with the presence
of the alditol acetate derivatives originating from GPLs
(not shown). Overall, the results of the GC-MS analysis
and the results of the TLC analysis are in agreement
with each other and, coupled with our genetic
complementation-controlled analysis, conclusively dem-
onstrate that gplH is essential for production of GPLs.
Based on the recent elucidation of the function of
MbtH-like proteins as amino acid adenylation domain
activators [36-40], it is reasonable to propose that GplH
is required for the assembly of the D-Phe-D-alloThr-D-
Ala-L-alaninol core moiety of GPLs by the Mps1-Mps2
NRPS system. GplH might act as a critical activator of
the amino acid adenylation activity of one or more of
the four amino acid adenylation domains predicted by
sequence analysis of the Mps1-Mps2 NRPS system
[22,23]. Biochemical studies will be required to investi-
gate this possibility.
Figure 3 Sequence relatedness of GplH orthologues and related homologues. (A) Protein alignment and (B) table of percentage of amino
acid identity. Conserved amino acids that match consensus are highlighted in white font over black background. The three conserved tryptophan
residues that are the hallmark of the MbtH-like protein family are marked (*). The protein alignment and identity determination were performed
with ClustalW (Lasergene software, DNASTAR, Inc). Mab, M. abscessus; Ma, M. avium; Map, M. avium subsp. paratuberculosis; Mc, M. chelonae;
Mi, M. intracellulare; Ms, M. smegmatis; Mt, M. tuberculosis.
Tatham et al. BMC Microbiology 2012, 12:118 Page 5 of 14
http://www.biomedcentral.com/1471-2180/12/118
MbtH-mediated cross-talk between GPL biosynthesis
and mycobactin biosynthesis
We noted that Ms has two potential mbtH-like genes
located outside the GPL biosynthetic gene cluster. One
of these genes is the mbtH orthologue in the mycobactin
biosynthetic gene cluster of Ms mentioned above [35].
The second gene, MSMEG_0016, is clustered with genes
implicated in the production of the siderophore exoche-
lin [48-50]. The protein products of these two Ms gplH
paralogues have considerable amino acid sequence iden-
tity between themselves and with GplH and M. tubercu-
losis MbtH (Figure 3B). The GPL deficiency of Ms
ΔgplH indicates that neither of these two Ms gplH para-
logues can support the production of GPLs in Ms ΔgplH
to a meaningful level under our culturing conditions.
It is worth noting that Ms mbtH and MSMEG_0016
are associated with siderophore production pathways
known to be repressed during growth under iron-rich
conditions [51,52]. This fact raises the possibility that
neither of these genes is expressed (or they are poorly
expressed) in the iron-rich standard Middlebrook media
used in our studies. With this consideration in mind, we
explored whether an increase in expression of Ms mbtH
(encoding the paralogue with the higher homology to
GplH, Figure 3) could complement the GPL deficiency
of Ms ΔgplH. To this end, we evaluated GPL production
in Ms ΔgplH after transformation of the mutant with
pCP0-mbtHMs (expressing Ms mbtH). TLC analysis of
lipid extracts from the transformant revealed the pres-
ence of GPLs, thus indicating that plasmid-directed con-
stitutive expression of Ms mbtH complements the GPL
deficient phenotype of Ms ΔgplH (Figure 5). Thus, it
appears that Ms MbtH has the potential to functionally
replace GplH if present in sufficient quantities. This
Figure 4 Construction of M. smegmatis ΔgplH. (A) Scheme illustrating the deletion in the chromosome of Ms ΔgplH. The position of each
primer used in this study is shown. (B) Scheme of the gplH deletion cassette-delivery suicide vector used for construction of Ms ΔgplH. The gplH
deletion leaves behind a gene remnant coding for only the first 13 (black print) and last 4 (white print) amino acids of GplH. This gene remnant
in ΔgplHc is flanked by ~1 kb of downstream and upstream WT sequence for homologous recombination with the chromosome. (C) Agarose
gel electrophoresis showing PCR-based confirmation of the gplH deletion in Ms ΔgplH. Lanes: 1, Ms WT (2,239-bp amplicon expected with
primers pepOF and pepOR); 2, Ms ΔgplH (2,068-bp amplicon expected with primers pepOF and pepOR); 3, Ms WT (278-bp amplicon expected
with primers pepF and pepR); 4, Ms ΔgplH (101-bp amplicon expected with primers pepF and pepR); L, DNA ladder marker.
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cross-complementation phenomenon is in line with
recent cell-based studies demonstrating MbtH-like pro-
tein-mediated cross-talk between NRPS systems [41,44].
Our finding is also consistent with reported in vitro
enzymology indicating that, at least in some cases, the
activity of amino acid adenylation domains of NRPSs can
be stimulated not only by bona fide MbtH-like protein
partners, but also by MbtH-like protein homologues from
disparate natural product biosynthetic pathways [39,40].
Deletion of gplH leads to a pleiotropic phenotype
Colony morphotype, biofilm formation and sliding
motility are properties that have been shown to be altered
in GPL deficient mutants [18-20,23]. Loss of GPL also
perturbs bacterial surface properties [19,32] and reduces
the cell-wall permeability barrier to chenodeoxycholate
uptake [19]. Interestingly, an altered profile of GPLs has
been observed in drug-resistant MAC isolates [21]. This
finding raises the possibility that GPL production might
have an impact on antimicrobial drug susceptibility as
well. We investigated whether deletion of gplH had an
effect on all these properties. Ms WT+pCP0 and Ms
ΔgplH+pCP0, rather than their respective plasmid-free
parental strains, were used in the experiments so that the
WT, the mutant, and the complemented Ms ΔgplH+
pCP0-gplH strain could all be cultured under identical
conditions (i.e., kanamycin-containing growth media) for
comparative analysis. Representative results from these
studies are shown in Figure 7.
Ms is known to develop into smooth, reddish colonies
with a glossy and translucent appearance when grown
on low carbon source congo red agar plates [23]. As
expected, Ms WT+pCP0 displayed this characteristic
morphotype in our congo red agar plate assay
(Figure 7A). Ms ΔgplH+ pCP0, however, had a drastic-
ally different morphotype. The mutant was characterized
by rough, whitish colonies with a non-translucent and
dried appearance. The strain Ms ΔgplH+ pCP0-gplH had
a morphotype more similar to WT than to that of the
mutant, indicating partial complementation by episomal
expression of gplH in the congo red agar assay. Deletion
of gplH also altered the ability of Ms to form biofilms
(Figure 7B). Ms WT+pCP0 formed a continuous, thin
biofilm at the liquid-air interface, as expected based on
previous reports [53,54]. In contrast, Ms ΔgplH+ pCP0
failed to develop such a biofilm and instead grew as
chunky patches on the liquid surface. The strain Ms
ΔgplH+ pCP0-gplH produced biofilms comparable to
those seen with Ms WT+pCP0. Sliding motility was
also compromised in Ms ΔgplH+ pCP0 (Figure 7C). The
mutant did not show sliding motility, whereas Ms WT+
pCP0 was highly active in the motility assay. Ms ΔgplH+
pCP0-gplH also displayed sliding motility, although the
motility was somewhat reduced compared to WT. This
observation indicates partial complementation by episo-
mal expression of gplH. Overall, these results clearly indi-
cate that deletion of gplH has a profound impact on
colony morphotype, biofilm formation, and sliding motil-
ity. These mutant phenotypes have previously been asso-
ciated with other GPL deficient strains and attributed to
alterations of the properties of the cell surface due to lack
of GPLs. Thus, it is likely that the phenotypes observed in
the gplH mutant arise from its GPL deficiency.
In contrast to the drastic impact of the gplH deletion on
colony morphotype, biofilm formation and sliding motility,
lack of gplH had a relatively minor effect on antimicrobial
drug susceptibility. When compared with Ms WT+pCP0
(control strain), Ms ΔgplH+pCP0 showed a slight, yet
consistent, increase in susceptibility to only two drugs
(cefuroxime and cefotaxime) from a panel of 15 drugs of
different classes tested in standard disk diffusion assays.
Interestingly, these two drugs belong to the cephalo-
sporin class, suggesting that the hypersusceptibility of
the mutant is antibiotic-class dependent. Representative
results illustrating the hypersusceptibility of the mutant
to these cephalosporins are shown in Figure 7D.
Streptomycin susceptibility results are also shown in
Figure 7D. The streptomycin susceptibility is presented
as an example of those drugs to which the mutant had
no meaningful difference in susceptibility relative to the
WT control. The Ms ΔgplH+ pCP0-gplH strain showed
a drug susceptibility pattern similar to that of Ms WT+
pCP0, indicating that the hypersusceptible phenotype of
Figure 5 Deletion of gplH leads to GPL deficiency.
Representative TLC analysis of lipid samples from: Ms WT; 2, Ms
WT+pCP0; 3, Ms ΔgplH; 4, Ms ΔgplH+pCP0; 5, Ms ΔgplH+pCP0-
gplH; and 6, Ms ΔgplH+pCP0-mbtHMs. The TLC solvent system is
indicated. Ori, origin; SF, solvent front.
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Figure 6 GC-MS analysis of alditol acetate derivatives of the glycosyl residues of GPLs. (A) Total ion count chromatographs displaying the
presence or absence of alditol acetates in extracted lipid samples from the strains indicated. (B) Mass spectra showing fragmentation pattern
fingerprints demonstrating alditol acetate identity in peaks labeled 2,3,4-trimethyl- rhamnose (1), 3,4-dimethyl-rhamnose (2), and 6-deoxy-talose
(3) from Ms WT+pCP0. Equivalent spectra were observed for the samples of Ms ΔgplH+pCP0-gplH (not shown). The selective ion monitoring MS
analysis of the mutant strain Ms ΔgplH revealed that the strain lacks the alditol acetate derivatives. For illustration clarity, only the m/z values of
selected diagnostic molecular ions are indicated in the spectra. These molecular ions arise from the fragmentation patterns of the corresponding
alditol acetates as displayed next to each spectrum.
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the mutant was complemented by episomal expression
of gplH.
The molecular mechanism behind the cephalosporin
hypersusceptibility arising from the lack of gplH remains
obscure. It is generally believed that the permeability
barrier imposed by the mycobacterial outer membrane
reduces antibiotic susceptibility by decreasing compound
penetration. Thus, it is tempting to hypothesize that the
observed cephalosporin hypersusceptibility arises from
an alteration in the permeability barrier of the outer
membrane of the gplH mutant due to the lack of GPLs.
The observation that lack of GPLs correlates with a
reduction in the permeability barrier to chenodeoxycho-
late uptake [19] is in line with this hypothesis. The
absence of GPLs might produce structural or fluidity
changes in the membrane that lead to an increase in
cephalosporin penetration. The fact that Ms ΔgplH
displays only a modest increase in antibiotic susceptibil-
ity suggests, however, that the lack of GPLs in the outer
membrane of the mutant does not have a profound
effect on the permeability barrier that this cell envelope
structure presents to drug penetration. Thus, our results
support the view that GPLs are not critical contributors
to the physical integrity of the permeability barrier of
the mycobacterial cell envelope.
Conclusions
Our results unambiguously demonstrate that the con-
served gene gplH is required for GPL production and
its inactivation leads to a pleiotropic phenotype. While
genes encoding members of the MbtH-like protein
family have been shown to be required for production
of siderophores or antibiotics [41-44], our findings pre-
sent the first case of one such gene required for
Figure 7 Pleiotropic phenotype of M. smegmatis ΔgplH. (A) Morphotype on the congo red agar plate assay. (B) Formation of biofilm at the
liquid-air interface. (C) Sliding motility analysis. (■) Ms WT+pCP0, (●) Ms ΔgplH+pCP0-gplH, (▲) Ms ΔgplH+pCP0. Data points are means of
duplicates ± SEM. The dashed line marks the diameter of the agar plate. (D) Antimicrobial drug susceptibility. Results shown are representative of
four determinations.
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biosynthesis of a cell wall component. Furthermore,
gplH is the first mbtH-like gene with proven functional
role in a member of the Mycobacterium genus.
Altogether, this study formally demonstrates a critical
role for gplH in mycobacterial biology and advances our
understanding of the genetic requirements for the bio-
synthesis of an important group of constituents of the
unique mycobacterial outer membrane.
Methods
Culturing conditions and recombinant DNA
manipulations
Ms strain mc2155 (ATCC 700084) and its derivatives
were routinely cultured under standard conditions (37°C,
225 rpm) in Middlebrook 7H9 (Difco) supplemented with
10% ADN (5% BSA, 2% dextrose, 0.85% NaCl), 0.2% gly-
cerol and 0.05% Tween-80 (supplemented 7H9) or in
Middlebrook 7H11 (Difco) supplemented with 10% ADN
(supplemented 7H11) [55]. E. coli DH5α (Invitrogen) was
cultured under standard conditions in Luria-Bertani
media [56]. When required, kanamycin (30 μg/ml), hygro-
mycin (50 μg/ml), sucrose (2%) and/or X-gal (70 μg/ml)
were added to the media. General recombinant DNA
manipulations were carried out by standard methods and
using E. coli as the primary cloning host [56]. Molecular
biology reagents were obtained from Sigma, Invitrogen,
New England Biolabs, Novagen, QIAGEN, or Stratagene.
Oligonucleotides were purchased from Integrated DNA
Technologies, Inc. PCR-generated DNA fragments used
in plasmid constructions were sequenced to verify fidelity.
Chromosomal DNA isolation from and plasmid electro-
poration into mycobacteria were carried out as reported
[55]. Table 1 lists the plasmids and oligonucleotide pri-
mers used in this study.
Construction of M. smegmatis ΔgplH
Ms ΔgplH was engineered using the p2NIL/pGOAL19-
based flexible cassette method [57] as previously reported
[4,31,35,58]. A suicide delivery vector (p2NIL-GOALc-
ΔgplHc, see below) carrying a gplH (MSMEG_0399) dele-
tion cassette (ΔgplHc) was used to generate Ms ΔgplH.
The vector was electroporated into Ms and transfor-
mants with a potential p2NIL-GOALc-ΔgplHc integra-
tion via a single-crossover event (blue colonies) were
selected on supplemented 7H11 containing hygromycin,
kanamycin, and X-gal. The selected transformants were
then grown in antibiotic-free supplemented 7H9, and
subsequently plated for single colonies on supplemented
7H11 containing sucrose and X-gal. White colonies that
grew on the sucrose plates were re-streaked onto
antibiotic-free and antibiotic-containing supplemented
7H11 plates to identify clones that lost drug resistance,
a trait indicating a possible double-crossover event with
consequent loss of gplH or reversion to WT. The dele-
tion of gplH in antibiotic sensitive clones was screened
for and confirmed by PCR. Towards this end, chromo-
somal DNA isolated from mutant candidates was used as
template along with primer pairs (pepOF and pepOR,
pepF and pepR) that produced diagnostic amplicons per-
mitting differentiation between the mutant and WT
genotypes.
Construction of p2NIL-GOALc-ΔgplHc and pCP0-gplH
The plasmid p2NIL-GOALc-ΔgplHc used in the con-
struction of Ms ΔgplH carried the gplH deletion cassette
ΔgplHc. The deletion cassette contained: 995-bp seg-
ment upstream of gplH+ gplH’s first 13 codons (5´ frag-
ment) followed by gplH’s last 4 codons + stop codon +
1,000-bp segment downstream of gplH (3´ fragment).
Table 1 Plasmids and oligonucleotide primers
Plasmid Characteristics Source or Reference
pCR2.1-TOPO Cloning vector, kanamycin resistance and ampicillin resistance genes Invitrogen
pCP0 Vector for gene expression in mycobacteria, kanamycin resistance gene [4]
pCP0-gplH pCP0 expressing M. smegmatis gplH This study
pCP0-mbtHMs pCP0 expressing M. smegmatis mbtH (MSMEG_4508) [35]
p2NIL Kanamycin resistance gene and OriE [57]
pGOAL19 Hygromycin resistance gene, sacB-lacZ PacI cassette, and OriE [57]
p2NIL-GOALc-ΔgplHc Delivery vector carrying a gplH deletion cassette (ΔgplHc) This study
Oligonucleotide Sequence (5’ to 3’) Characteristics
pepOF GGTACCTGTTCAACGCGGCCAGAGCGTCATTGGTCTCGGCCA KpnI
pepOR TTAATTAATGTTGCAACAGCTCCCTGATCCGGATGTCGACGTGCTTG PacI
pepIR TCAGCCGTCAAGAGCAAAGCTGCCGTTGTCGTCATCGAACGGGTTGAT SOE PCR
pepIF CGACAACGGCAGCTTTGCTCTTGACGGCTGAGTCAAATAGTCTGTTG SOE PCR
pepF CTGCAGTGAACAGCCGGGAGAAACGT PstI
pepR AAGCTTCCCAACAGACTATTTGACTCAGCCG HindIII
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ΔgplHc was built by the joining of the 5' fragment and
the 3' fragment using splicing-by-overlap-extension
(SOE) PCR [59]. Each fragment was PCR-generated
from chromosomal DNA. Primer pair pepOF and pepIR
and primer pair pepIF and pepOR were used to generate
the 5’ and 3’ fragments, respectively. The fragments were
then used as template for PCR with primers pepOF and
pepOR to fuse the fragments and create ΔgplHc
(2,061 bp). The PCR-generated ΔgplHc was first cloned
into pCR2.1-TOPO (Invitrogen). ΔgplHc was subse-
quently excised from the pCR2.1-TOPO construct using
KpnI and PacI, and the excerpt was ligated to p2NIL
[57] linearized by KpnI-PacI digestion. The resulting
p2NIL-ΔgplHc plasmid and plasmid pGOAL19 [57]
were digested with PacI, and the PacI cassette (GOALc,
7,939 bp) of pGOAL19 was ligated to the linearized
p2NIL-ΔgplHc to create p2NIL-GOALc-ΔgplHc. To
create pCP0-gplH, the plasmid used for complementa-
tion analysis, a DNA fragment (266 bp) encompassing
gplH and its predicted ribosome binding site (RBS) was
PCR-amplified from genomic DNA with primer pair
pepF and pepR and cloned into pCR2.1-TOPO. The
RBS-gplH fragment was subsequently excised from the
pCR2.1-TOPO construct using PstI and HindIII and
ligated to plasmid pCP0 [4] linearized by PstI-HindIII di-
gestion to create pCP0-gplH. The cloning placed gplH
under the control of the hsp60 promoter of pCP0 for
gene expression in mycobacteria.
Extraction and thin layer chromatography (TLC) analysis
of GPLs
GPLs were extracted and analyzed by TLC by reported
methods [22,60]. Cells from cultures (5 ml, OD600
of 1.3-1.6) grown in supplemented 7H9 as described
above were collected by centrifugation (4,700 × g,
15 min), washed with cold phosphate buffered saline
(PBS, 1 ml), and processed for GPL extraction. GPLs
were extacted with 2:1 CHCl3/CH3OH (20 μl/mg wet
weight) by incubation overnight at room temperature in
a rocking shaker. After incubation, insoluble material
was removed by centrifugation (18,400 × g, 10 min), and
the CHCl3/CH3OH supernatant was recovered and
mixed with 0.2 volumes of 0.9% NaCl. After vigorous
vortexing, the mixture was centrifuged (1,150 × g,
5 min) and the organic phase (containing GPLs) was col-
lected and evaporated to dryness. The dried lipid
extracts were dissolved in 20 μl of CHCl3/CH3OH (2:1)
and subjected to TLC using aluminum-backed, 250-μm
silica gel F254 plates developed with CHCl3/CH3OH
(100:7). After chromatography, TLC plates were sprayed
with orcinol/sulfuric acid (0.1% orcinol in 40% sul-
furic acid) and glycolipids were detected by charring
at 140°C.
Preparation and gas chromatography–mass spectrometry
(GC-MS) analysis of alditol acetate derivatives
Alditol acetate derivatives of glycosyl units from GPLs
were prepared and analyzed as reported [47,61]. Briefly,
lipid samples prepared by extraction as noted above
were acid-hydrolyzed in 250 μl of 2 M trifluoroacetic
acid for 2 hr at 120°C. After cooling down to room
temperature, samples were hexane-washed (250 μl) and
dried on air bath after adding 1 μg of 3,6-O-dimethyl-
glucose as an internal standard. The hydrolyzed sugars
were reduced overnight at room temperature by adding
250 μl of NaBD4 (prepared at 10 mg/ml in 1 M NH4OH
in C2H5OH). After reduction, glacial acetic acid (20 μl)
was added to remove excess NaBD4 and the samples
were dried. CH3OH (100 μl) was added to each sample,
and after resuspension the solvent was evaporated
to dryness (this step was repeated twice). The samples
were per-O-acetylated with 100 μl of acetic anhydride
at 120°C for 2 hr. After cooling, the samples were dried
on air bath and suspended in 3 ml of CHCl3/H2O (2:1)
by vortexing. The organic layer was extracted after
centrifugation (2,500 × g, 5 min, 4°C) and dried on air
bath. GC-MS analysis was performed using a Varian CP-
3800 gas chromatograph (Varian Inc., Palo Alto, CA)
equipped with a MS-320 mass spectrometer and using
helium gas. The alditol acetate derivatives were dissolved
in 50 μl of CHCl3 before injection on a DB 5 column
(30 m× 0.20 mm inner diameter) with an initial oven
temperature of 50°C for 1 min, followed by an increase
of 30°C/min to 150°C and finally to 275°C at 5°C/min.
Congo red agar plate assay
The assay was carried out using reported methodologies
[23]. Briefly, mycobacterial cultures (5 ml, OD600 = 1.5)
were shortly vortexed with glass beads to increase homo-
geneity and then centrifuged (4,700 × g, 15 min) for cell
collection. The collected cells were washed with PBS
(5 ml) and subsequently resuspended in PBS to an OD600
of 1. The cell suspensions were spotted (2 μl) on congo
red agar plates [23] (7H9 basal medium, 1.5% agar,
100 μg/ml congo red (sodium salt of 3,3'-([1,1'-biphenyl]-
4,4'-diyl)bis(4-aminonaphthalene-1-sulfonic acid), Sigma
Aldrich Co.), 0.02% glucose, 30 μg/ml kanamycin). Col-
ony morphology was examined using an Olympus SZX7
stereo microscope after plate incubation (37°C, 3 days).
Sliding motility test
The test was performed by standard methods [19].
Briefly, mycobacterial cell suspensions in PBS prepared
as noted above were spotted (2 μl) on sliding motility
assay plates [19] (7H9 basal medium, 0.3% agarose,
30 μg/ml kanamycin). The sliding motility plates were
incubated at 37°C and the degree of spreading (diameter
Tatham et al. BMC Microbiology 2012, 12:118 Page 11 of 14
http://www.biomedcentral.com/1471-2180/12/118
of growth zone) was determined at the time points indi-
cated in results.
Biofilm formation assay
The liquid-air interface biofilm assay was conducted
based on reported methods [53]. Overnight mycobacter-
ial cultures (5 ml) grown in supplemented 7H9 as noted
above were centrifuged (4,700 × g, 15 min) for cell col-
lection. The cells were washed twice with 5 ml of sup-
plemented 7H9 without Tween-80. After washing, the
cells were resuspended in supplemented 7H9 without
Tween-80 to a calculated OD600 of 10. A 25 μl aliquot of
each suspension was inoculated onto the surface of
2.5 ml of supplemented 7H9 without Tween-80 loaded
into a well of a 12-well polystyrene plate. The plate was
incubated for 4 days without shaking at 37°C before
examination for biofilm formation.
Drug susceptibility assay
Standard disk-diffusion assays were carried out as reported
[58,62]. Exponentially growing cultures (OD600= 0.6) in
supplemented 7H9 were diluted in fresh medium to an
OD600 of 0.05, and 100 μl of diluted culture were used
to seed 7H11 plates (20 ml agar/plate). Antibiotic disks
were placed onto the inoculated agar and the plates were
incubated at 37°C for 2 days before analysis. The anti-
biotics tested were doxycycline, isoniazid, streptomycin,
tetracycline, cefuroxime, erythromycin, ciprofloxacin, levo-
floxacin, ethambutol, ethionamide, rifampicin, clarithro-
mycin, cefuroxime, cephalexin, and cefotaxime. The
antibiotics were acquired from Sigma-Aldrich, Fisher
Scientific, Tokyo Chemical Industry, or Calbiochem
Biochemicals.
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